<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00284713</url>
  </required_header>
  <id_info>
    <org_study_id>TOPCARE-DCM</org_study_id>
    <nct_id>NCT00284713</nct_id>
  </id_info>
  <brief_title>Progenitor Cell Therapy in Dilative Cardiomyopathy</brief_title>
  <official_title>Transplantation Of Progenitor Cells And Recovery Of Left Ventricular Function In Patients With Nonischemic Dilatative Cardiomyopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intracoronary infusion of bone marrow derived progenitor cells into the LAD in patients with
      non ischemic dilated cardiomyopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Initial clinical pilot trials suggested that intracoronary infusion of bone marrow-derived
      progenitor cells (BMC) may enhance left ventricular functional recovery in patients with
      acute myocardial infarction. It is unknown, however, whether such a strategy might also be
      applicable to patients with non-ischemic dilated cardiomyopathy (DCM). Therefore, we
      initiated the TOPCARE-DCM - trial (Transplantation Of Progenitor Cells And Recovery of Left
      Ventricular Function in Patients with non ischemic Dilatative CardioMyopathy) aiming to
      regionally improve left ventricular contractility by selective infusion of BMC into the left
      anterior descending coronary artery.

      Patients will be randomized 2:1 (20/10) BMC Infusion versus standard medical therapy
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2004</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LV function (Ejection fraction within 3 months) Simpson</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure, Congestive</condition>
  <condition>Cardiomyopathy, Dilated</condition>
  <condition>Stem Cell Transplantation</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intracoronary infusion of BMC</intervention_name>
    <description>catheter delivery of stem cells</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 8-80

          -  Dilated Cardiomyopathy, Ejection fraction &lt; 40%

          -  LVEDD &gt; 60mm

          -  Stable clinical condition within last 6 months

          -  Written informed consent

        Exclusion Criteria:

          -  Myocardial infarction or coronary intervention in the past

          -  Change of medical therapy within the last 6 weeks prior to cell therapy

          -  Tumor within last 5 years or incomplete remission

          -  Active infection

          -  Active bleeding

          -  Stroke within last 2 years

          -  Surgery or trauma within last 2 months

          -  Uncontrolled hypertension

          -  HIV infection

          -  Chronic inflammatory disease

          -  Liver disease (GOT &gt; 2x upper normal limit)

          -  Renal dysfunction (creatinin &gt; 2.0mg/dl)

          -  Thrombopenia &lt; 100.000

          -  Anemia (hemoglobin &lt; 8.5 g/dl)

          -  Mental retardation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas M Zeiher</last_name>
    <role>Principal Investigator</role>
    <affiliation>Div. of Cardiology, University of Frankfurt, Germany</affiliation>
  </overall_official>
  <removed_countries>
    <country>Germany</country>
  </removed_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2006</study_first_submitted>
  <study_first_submitted_qc>January 31, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2006</study_first_posted>
  <last_update_submitted>February 17, 2009</last_update_submitted>
  <last_update_submitted_qc>February 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2009</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

